Literature DB >> 2303847

Agreement of self-reported ovarian number following gynecologic surgery with medical record reports.

K L Irwin1, P A Wingo, N C Lee.   

Abstract

In case-control studies of breast cancer, cardiovascular disease, and osteoporosis, a woman's ovarian function may be considered as a main exposure, confounding factor, or effect modifier. To evaluate the agreement between self-reported ovarian number following ovarian surgery for nonmalignant disease and medical record reports, we analyzed data from a population-based case-control study, the Cancer and Steroid Hormone Study. Reports on ovarian number after the most recent surgery for a who had been diagnosed with breast cancer and 496 control subjects. We then calculated agreement rates by comparing the number of ovaries indicated by the medical record with the number reported by the woman. Agreement rates on the presence or absence of ovaries exceeded 90% for both case and control subjects. Agreement rates on exact ovarian number exceeded 84% for both groups. Women who had been diagnosed with breast cancer had slightly higher agreement rates than did control women for both presence or absence of ovaries and exact ovarian number. Our data suggest that investigators can rely on self-reported ovarian number as an accurate measure of actual ovarian number in women who have had surgery for nonmalignant conditions.

Entities:  

Mesh:

Year:  1990        PMID: 2303847     DOI: 10.1016/0895-4356(90)90182-o

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  9 in total

1.  Hysterectomy status, estrogen use and quality of life in older women: the Rancho Bernardo study.

Authors:  Donna Kritz-Silverstein; Denise G Von Muhlen; Theodore G Ganiats; Elizabeth Barrett-Connor
Journal:  Qual Life Res       Date:  2004-02       Impact factor: 4.147

2.  Hysterectomy, oophorectomy, and heart disease risk factors in older women.

Authors:  D Kritz-Silverstein; E Barrett-Connor; D L Wingard
Journal:  Am J Public Health       Date:  1997-04       Impact factor: 9.308

3.  Long-term overall and disease-specific mortality associated with benign gynecologic surgery performed at different ages.

Authors:  Gretchen L Gierach; Ruth M Pfeiffer; Deesha A Patel; Amanda Black; Catherine Schairer; Abegail Gill; Louise A Brinton; Mark E Sherman
Journal:  Menopause       Date:  2014-06       Impact factor: 2.953

4.  Bilateral oophorectomy, body mass index, and mortality in U.S. women aged 40 years and older.

Authors:  Anne Marie McCarthy; Andy Menke; Pamela Ouyang; Kala Visvanathan
Journal:  Cancer Prev Res (Phila)       Date:  2012-05-03

5.  Change in sexual functioning over the menopausal transition: results from the Study of Women's Health Across the Nation.

Authors:  Nancy E Avis; Alicia Colvin; Arun S Karlamangla; Sybil Crawford; Rachel Hess; L Elaine Waetjen; Maria Brooks; Ping G Tepper; Gail A Greendale
Journal:  Menopause       Date:  2017-04       Impact factor: 2.953

6.  Association of bilateral oophorectomy and body fatness in a representative sample of US women.

Authors:  Anne Marie McCarthy; Andy Menke; Kala Visvanathan
Journal:  Gynecol Oncol       Date:  2013-02-18       Impact factor: 5.482

7.  General practitioner notes as a source of information for case-control studies in young women. UK National Case-Control Study Group.

Authors:  C E Chilvers; M C Pike; C N Taylor; C Hermon; B Crossley; S J Smith
Journal:  J Epidemiol Community Health       Date:  1994-02       Impact factor: 3.710

8.  Validation of self-reported history of hysterectomy and oophorectomy among women in an integrated group practice setting.

Authors:  Amanda I Phipps; Diana S M Buist
Journal:  Menopause       Date:  2009 May-Jun       Impact factor: 2.953

9.  Association of Oophorectomy and Fat and Lean Body Mass: Evidence from a Population-Based Sample of U.S. Women.

Authors:  Pritesh S Karia; Corinne E Joshu; Kala Visvanathan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-04-20       Impact factor: 4.254

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.